Outcome of Chronic Daily Headache or Chronic Migraine (Q38676484)

5 September 2017

title

Outcome of Chronic Daily Headache or Chronic Migraine (English)

1 reference

5 September 2017

1 reference

1 reference

1 reference

Soo-Jin Cho

1 reference

5 September 2017

Tae-Jin Song

series ordinal

1 reference

5 September 2017

Min Kyung Chu

series ordinal

1 reference

5 September 2017

language of work or name

English

0 references

publication date

1 January 2016

1 reference

Current Pain and Headache Reports

5 September 2017

published in

1 reference

5 September 2017

1 reference

5 September 2017

1 reference

5 September 2017

1 reference

Clinical practice. Chronic daily headache

5 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11916-015-0534-8

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-015-0534-8

Chronic migraine and chronic daily headache in the Asia-Pacific region: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-015-0534-8

21 January 2018

Chronic daily headache

1 reference

https://api.crossref.org/works/10.1007%2FS11916-015-0534-8

Primary chronic daily headache and its subtypes in adolescents and adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-015-0534-8

The International Classification of Headache Disorders, 3rd edition (beta version)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-015-0534-8

Operational diagnostic criteria for chronic migraine: expert opinion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-015-0534-8

Chronic migraine: epidemiology and disease burden

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-015-0534-8

Global prevalence of chronic migraine: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-015-0534-8

Disability, HRQoL and resource use among chronic and episodic migraineurs: results from the International Burden of Migraine Study (IBMS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-015-0534-8

Burden of migraine: international perspectives.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-015-0534-8

Defining the differences between episodic migraine and chronic migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-015-0534-8

Migraine: the seventh disabler

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-015-0534-8

Quality of life impairment, disability and economic burden associated with chronic daily headache, focusing on chronic migraine with or without medication overuse: a systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-015-0534-8

Sick leave is related to frequencies of migraine and non-migrainous headache--The HUNT Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-015-0534-8

Chronic migraine in the population: burden, diagnosis, and satisfaction with treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-015-0534-8

Economic burden and costs of chronic migraine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-015-0534-8

Tackling chronic migraine: current perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-015-0534-8

The prevalence and burden of primary headaches in China: a population-based door-to-door survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-015-0534-8

The prevalence and impact of headache in Brazil

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-015-0534-8

Prevalence, management and burden of episodic and chronic headaches--a cross-sectional multicentre study in eight Austrian headache centres

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-015-0534-8

Chronic migraine prevalence, disability, and sociodemographic factors: results from the American Migraine Prevalence and Prevention Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-015-0534-8

The impact of chronic migraine: The Chronic Migraine Epidemiology and Outcomes (CaMEO) Study methods and baseline results

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-015-0534-8

Validating Migraine‐Specific Quality of Life Questionnaire v2.1 in Episodic and Chronic Migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-015-0534-8

The EUROHIS-QOL 8-item index: comparative psychometric properties to its parent WHOQOL-BREF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-015-0534-8

The MOS 36-ltem Short-Form Health Survey (SF-36)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-015-0534-8

Impact of headache on quality of life in a general population survey in France (GRIM2000 Study).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-015-0534-8

Psychosocial aspects of chronic daily headache

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-015-0534-8

Quality of life in chronic daily headache: a study in a general population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-015-0534-8

Quality-of-life differences between patients with episodic and transformed migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-015-0534-8

Quality of life differs among headache diagnoses: analysis of SF-36 survey in 901 headache patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-015-0534-8

Epidemiological classification and social impact of chronic headache

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-015-0534-8

Headache and quality of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-015-0534-8

The Global Campaign, World Health Organization and Lifting The Burden: collaboration in action

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-015-0534-8

Diagnosis, prevalence estimation and burden measurement in population surveys of headache: presenting the HARDSHIP questionnaire

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-015-0534-8

Sociodemographic and comorbidity profiles of chronic migraine and episodic migraine sufferers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-015-0534-8

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-015-0534-8

Economic burden of transformed migraine: results from the American Migraine Prevalence and Prevention (AMPP) Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-015-0534-8

Comparisons of disability, quality of life, and resource use between chronic and episodic migraineurs: a clinic-based study in Taiwan

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-015-0534-8

Chronic daily headache in Korea: prevalence, clinical characteristics, medical consultation and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-015-0534-8

Employment and work impact of chronic migraine and episodic migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-015-0534-8

Emerging treatment for chronic migraine and refractory chronic migraine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-015-0534-8

Antiepileptics in migraine prophylaxis: an updated Cochrane review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-015-0534-8

Memantine in the preventive treatment of refractory migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-015-0534-8

Pregabalin in the treatment of chronic migraine: an open-label study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-015-0534-8

Atenolol in the prophylaxis of chronic migraine: a 3-month open-label study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-015-0534-8

Botulinum toxin type A versus amitriptyline for the treatment of chronic daily migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-015-0534-8

Chronic daily headache prophylaxis with tizanidine: a double-blind, placebo-controlled, multicenter outcome study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-015-0534-8

The effect of sodium valproate on chronic daily headache and its subgroups

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-015-0534-8

Behavioral therapy for chronic migraine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-015-0534-8

Combined occipital and supraorbital neurostimulation for the treatment of chronic migraine headaches: initial experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-015-0534-8

Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-015-0534-8

Efficacy and safety of topiramate for the treatment of chronic migraine: a randomized, double-blind, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-015-0534-8

Topiramate for migraine prevention: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-015-0534-8

Topiramate in migraine prevention: a double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-015-0534-8

OnabotulinumtoxinA for treatment of chronic migraine: pooled results from the double-blind, randomized, placebo-controlled phases of the PREEMPT clinical program

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-015-0534-8

Assessment: Botulinum neurotoxin in the treatment of autonomic disorders and pain (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-015-0534-8

Gabapentin in the prophylaxis of chronic daily headache: a randomized, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-015-0534-8

Defining refractory migraine: results of the RHSIS Survey of American Headache Society members

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-015-0534-8

Refractory migraine in a headache clinic population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-015-0534-8

Safety and efficacy of peripheral nerve stimulation of the occipital nerves for the management of chronic migraine: long-term results from a randomized, multicenter, double-blinded, controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-015-0534-8

tDCS-induced analgesia and electrical fields in pain-related neural networks in chronic migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-015-0534-8

Chronic Daily Headache in Taipei, Taiwan: Prevalence, Follow-Up and Outcome Predictors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-015-0534-8

Acupuncture versus topiramate in chronic migraine prophylaxis: a randomized clinical trial

21 January 2018

1 reference

12 December 2020

OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial

1 reference

12 December 2020

Assessment of migraine disability using the migraine disability assessment (MIDAS) questionnaire: a comparison of chronic migraine with episodic migraine

1 reference

12 December 2020

Patterns of health care utilization for migraine in England and in the United States

1 reference

12 December 2020

Prevalence and description of chronic daily headache in the general population in France

1 reference

12 December 2020

The International Classification of Headache Disorders: 2nd edition

1 reference

12 December 2020

European principles of management of common headache disorders in primary care

1 reference

12 December 2020

OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial

1 reference

12 December 2020

Preventive treatment of chronic migraine with zonisamide: a study in patients who are refractory or intolerant to topiramate

1 reference

12 December 2020

Prognostic factors, disability, and functional status among patients in a headache specialty practice

1 reference

12 December 2020

Quality of life and disability in primary chronic daily headaches.

1 reference

12 December 2020

1 reference

12 December 2020

Disability and quality of life in different primary headaches: results from Italian studies

1 reference

12 December 2020

Disability Pattern in Chronic Migraine With Medication Overuse: A Comparison With Migraine Without Aura

1 reference

12 December 2020

10.1007/S11916-015-0534-8

Identifiers

DOI

1 reference

Dimensions Publication ID

5 September 2017

1039515406

0 references

1 reference